Preliminary programme
SATURDAY 6 MARCH
Virtual meeting
9:00 – 9:05
BMUC opening and welcome
Thierry Roumeguère
9:05 – 9:30
Renal Cell Carcinoma (RCC)
Moderators: Maarten Albersen – Sylvie Rottey – Nora Sundahl
9:05 – Metastasis-directed therapy for oligometastatic RCC in the immunotherapy era
Shankar Siva
09:20 – Q&A
9:30 – 9:40
Research grant
Thierry Roumeguère
9:40 – 9:50
Coffee break
9:50 – 11:05
Prostate cancer
Moderators: Piet Dirix – Wouter Everaerts – Karolien Goffin
9:50 – Biomarker driven prostate cancer care: when prognostic biomarkers surpass predictive biomarkers
Daniel E. Spratt
10:10 – Q&A
10:20 – Practical issues of next generation sequencing in prostate cancer
Robin de Putter
10:30 – Q&A
10:35 – Optimum imaging strategies for advanced prostate cancer: ASCO guideline
Anwar Padhani
10:55 – Q&A
11:05 – 11:15
Coffee break
11:15 – 12:10
Bladder cancer
Moderators: Jean-Pascal Machiels – Thierry Roumeguère
Bladder preservation in muscle invasive bladder cancer
11:15 – Radiochemotherapy / radioimmunotherapy
Nora Sundahl
11:25 – Is neoadjuvant immunotherapy good enough?
Nieves Martinez-Chanza
11:35 – Yes / maybe we still need cystectomy
Jim Catto
11:45 – Q&A
12:00 – New molecules in bladder cancer
Marco Gizzi
12:10 – 12:20
Coffee break
12:20 – 12:45
Testicular cancer
Moderators: Karolien Goffin – Benjamin Ledoux – Brieuc Sautois
12:20 – Follow up of early testicular cancer: when and how long?
Robert Huddart
12:35 – Q&A
12:45 – 13:00
Take home messages
Sylvie Rottey
13:00
End of the meeting
RIZIV/INAMI and FANC accreditation points have been applied for.